BLUE CAP AG (B7E.DE) Fundamental Analysis & Valuation

FRA:B7E • DE000A0JM2M1

Current stock price

17.95 EUR
+0.15 (+0.84%)
Last:

This B7E.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. B7E.DE Profitability Analysis

1.1 Basic Checks

  • B7E had positive earnings in the past year.
  • B7E had a positive operating cash flow in the past year.
  • B7E had positive earnings in 4 of the past 5 years.
  • B7E had a positive operating cash flow in each of the past 5 years.
B7E.DE Yearly Net Income VS EBIT VS OCF VS FCFB7E.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

  • B7E has a Return On Assets of 9.48%. This is amongst the best in the industry. B7E outperforms 88.60% of its industry peers.
  • With an excellent Return On Equity value of 20.25%, B7E belongs to the best of the industry, outperforming 85.09% of the companies in the same industry.
  • B7E has a better Return On Invested Capital (6.33%) than 75.44% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for B7E is below the industry average of 9.10%.
  • The 3 year average ROIC (5.02%) for B7E is below the current ROIC(6.33%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.48%
ROE 20.25%
ROIC 6.33%
ROA(3y)0.97%
ROA(5y)2.64%
ROE(3y)1.48%
ROE(5y)6.13%
ROIC(3y)5.02%
ROIC(5y)5.41%
B7E.DE Yearly ROA, ROE, ROICB7E.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

  • B7E has a Profit Margin (11.71%) which is in line with its industry peers.
  • B7E's Profit Margin has improved in the last couple of years.
  • The Operating Margin of B7E (8.02%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of B7E has grown nicely.
  • B7E has a better Gross Margin (49.70%) than 66.67% of its industry peers.
  • In the last couple of years the Gross Margin of B7E has grown nicely.
Industry RankSector Rank
OM 8.02%
PM (TTM) 11.71%
GM 49.7%
OM growth 3Y20.55%
OM growth 5Y16.85%
PM growth 3Y49.43%
PM growth 5Y38.76%
GM growth 3Y2.24%
GM growth 5Y2.56%
B7E.DE Yearly Profit, Operating, Gross MarginsB7E.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. B7E.DE Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for B7E remains at a similar level compared to 1 year ago.
  • B7E has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, B7E has an improved debt to assets ratio.
B7E.DE Yearly Shares OutstandingB7E.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
B7E.DE Yearly Total Debt VS Total AssetsB7E.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • An Altman-Z score of 2.19 indicates that B7E is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.19, B7E is doing good in the industry, outperforming 71.05% of the companies in the same industry.
  • The Debt to FCF ratio of B7E is 4.61, which is a neutral value as it means it would take B7E, 4.61 years of fcf income to pay off all of its debts.
  • B7E has a better Debt to FCF ratio (4.61) than 78.95% of its industry peers.
  • A Debt/Equity ratio of 0.32 indicates that B7E is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.32, B7E is doing good in the industry, outperforming 65.79% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 4.61
Altman-Z 2.19
ROIC/WACCN/A
WACCN/A
B7E.DE Yearly LT Debt VS Equity VS FCFB7E.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • A Current Ratio of 1.73 indicates that B7E should not have too much problems paying its short term obligations.
  • The Current ratio of B7E (1.73) is better than 75.44% of its industry peers.
  • B7E has a Quick Ratio of 1.39. This is a normal value and indicates that B7E is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of B7E (1.39) is better than 71.93% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.39
B7E.DE Yearly Current Assets VS Current LiabilitesB7E.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. B7E.DE Growth Analysis

3.1 Past

  • B7E shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 292.72%, which is quite impressive.
  • B7E shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 33.00% yearly.
  • The Revenue has decreased by -0.59% in the past year.
  • B7E shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.79% yearly.
EPS 1Y (TTM)292.72%
EPS 3Y33.45%
EPS 5Y33%
EPS Q2Q%1599.7%
Revenue 1Y (TTM)-0.59%
Revenue growth 3Y-8.3%
Revenue growth 5Y-1.79%
Sales Q2Q%-4.28%

3.2 Future

  • Based on estimates for the next years, B7E will show a very negative growth in Earnings Per Share. The EPS will decrease by -53.34% on average per year.
  • The Revenue is expected to decrease by -5.75% on average over the next years.
EPS Next Y13.1%
EPS Next 2Y-89.98%
EPS Next 3Y-53.34%
EPS Next 5YN/A
Revenue Next Year-38.12%
Revenue Next 2Y-20.3%
Revenue Next 3Y-12.42%
Revenue Next 5Y-5.75%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
B7E.DE Yearly Revenue VS EstimatesB7E.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
B7E.DE Yearly EPS VS EstimatesB7E.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

7

4. B7E.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 3.98 indicates a rather cheap valuation of B7E.
  • Based on the Price/Earnings ratio, B7E is valued cheaper than 95.61% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.86. B7E is valued rather cheaply when compared to this.
  • Based on the Price/Forward Earnings ratio of 394.94, the valuation of B7E can be described as expensive.
  • B7E's Price/Forward Earnings is on the same level as the industry average.
  • B7E is valuated expensively when we compare the Price/Forward Earnings ratio to 37.39, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 3.98
Fwd PE 394.94
B7E.DE Price Earnings VS Forward Price EarningsB7E.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, B7E is valued cheaper than 96.49% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of B7E indicates a rather cheap valuation: B7E is cheaper than 94.74% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.79
EV/EBITDA 3.02
B7E.DE Per share dataB7E.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • B7E has a very decent profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as B7E's earnings are expected to decrease with -53.34% in the coming years.
PEG (NY)0.3
PEG (5Y)0.12
EPS Next 2Y-89.98%
EPS Next 3Y-53.34%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. B7E.DE Dividend Analysis

5.1 Amount

  • B7E has a Yearly Dividend Yield of 3.65%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 3.15, B7E pays a bit more dividend than its industry peers.
  • B7E's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.65%

5.2 History

  • The dividend of B7E decreases each year by -2.84%.
Dividend Growth(5Y)-2.84%
Div Incr Years0
Div Non Decr Years1
B7E.DE Yearly Dividends per shareB7E.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • The Dividend Rate of B7E has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP0%
EPS Next 2Y-89.98%
EPS Next 3Y-53.34%
B7E.DE Yearly Income VS Free CF VS DividendB7E.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

More info and screens

Find the best dividend stocksShow peers with best dividend

B7E.DE Fundamentals: All Metrics, Ratios and Statistics

BLUE CAP AG

FRA:B7E (4/10/2026, 7:00:00 PM)

17.95

+0.15 (+0.84%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)03-26
Earnings (Next)05-12
Inst Owners27.6%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap80.60M
Revenue(TTM)174.60M
Net Income(TTM)20.44M
Analysts82.5
Price Target30.55 (70.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.65%
Yearly Dividend0.65
Dividend Growth(5Y)-2.84%
DP0%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-1.05%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.59%
EPS NY rev (3m)79.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-0.01%
Valuation
Industry RankSector Rank
PE 3.98
Fwd PE 394.94
P/S 0.46
P/FCF 5.79
P/OCF 3.98
P/B 0.8
P/tB 1.52
EV/EBITDA 3.02
EPS(TTM)4.51
EY25.13%
EPS(NY)0.05
Fwd EY0.25%
FCF(TTM)3.1
FCFY17.27%
OCF(TTM)4.51
OCFY25.15%
SpS38.89
BVpS22.48
TBVpS11.77
PEG (NY)0.3
PEG (5Y)0.12
Graham Number47.76
Profitability
Industry RankSector Rank
ROA 9.48%
ROE 20.25%
ROCE 9.09%
ROIC 6.33%
ROICexc 9.23%
ROICexgc 16.8%
OM 8.02%
PM (TTM) 11.71%
GM 49.7%
FCFM 7.97%
ROA(3y)0.97%
ROA(5y)2.64%
ROE(3y)1.48%
ROE(5y)6.13%
ROIC(3y)5.02%
ROIC(5y)5.41%
ROICexc(3y)6.63%
ROICexc(5y)7.25%
ROICexgc(3y)11.85%
ROICexgc(5y)10.59%
ROCE(3y)7.26%
ROCE(5y)7.8%
ROICexgc growth 3Y54.39%
ROICexgc growth 5Y35.47%
ROICexc growth 3Y30.62%
ROICexc growth 5Y18.26%
OM growth 3Y20.55%
OM growth 5Y16.85%
PM growth 3Y49.43%
PM growth 5Y38.76%
GM growth 3Y2.24%
GM growth 5Y2.56%
F-Score8
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 4.61
Debt/EBITDA 1.04
Cap/Depr 37.43%
Cap/Sales 3.64%
Interest Coverage 3.69
Cash Conversion 65.44%
Profit Quality 68.08%
Current Ratio 1.73
Quick Ratio 1.39
Altman-Z 2.19
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)25.83%
Cap/Depr(5y)33.96%
Cap/Sales(3y)2.24%
Cap/Sales(5y)2.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)292.72%
EPS 3Y33.45%
EPS 5Y33%
EPS Q2Q%1599.7%
EPS Next Y13.1%
EPS Next 2Y-89.98%
EPS Next 3Y-53.34%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.59%
Revenue growth 3Y-8.3%
Revenue growth 5Y-1.79%
Sales Q2Q%-4.28%
Revenue Next Year-38.12%
Revenue Next 2Y-20.3%
Revenue Next 3Y-12.42%
Revenue Next 5Y-5.75%
EBIT growth 1Y224.21%
EBIT growth 3Y10.55%
EBIT growth 5Y14.76%
EBIT Next Year-25.32%
EBIT Next 3Y-22.28%
EBIT Next 5Y-14.12%
FCF growth 1Y-38.99%
FCF growth 3Y7.4%
FCF growth 5YN/A
OCF growth 1Y-27.35%
OCF growth 3Y1.47%
OCF growth 5Y47.8%

BLUE CAP AG / B7E.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BLUE CAP AG (B7E.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to B7E.DE.


What is the valuation status of BLUE CAP AG (B7E.DE) stock?

ChartMill assigns a valuation rating of 7 / 10 to BLUE CAP AG (B7E.DE). This can be considered as Undervalued.


How profitable is BLUE CAP AG (B7E.DE) stock?

BLUE CAP AG (B7E.DE) has a profitability rating of 7 / 10.


What is the financial health of BLUE CAP AG (B7E.DE) stock?

The financial health rating of BLUE CAP AG (B7E.DE) is 5 / 10.


What is the expected EPS growth for BLUE CAP AG (B7E.DE) stock?

The Earnings per Share (EPS) of BLUE CAP AG (B7E.DE) is expected to grow by 13.1% in the next year.